Lu Zhang
About Lu Zhang
Lu Zhang is an Associate Director at BeiGene in Shanghai, China, with a strong background in immunology and international work experience in the United States and China.
Title
Lu Zhang is currently an Associate Director at BeiGene, a global biotechnology company, located in Shanghai, China.
Company
BeiGene is a biotechnology company specializing in developing molecularly targeted and immuno-oncology drug candidates for the treatment of cancer. Lu Zhang is currently part of this dynamic organization as an Associate Director.
Education and Expertise
Lu Zhang has a strong academic background in immunology. He earned a Doctor of Philosophy (Ph.D.) in Immunology from the University of North Carolina at Chapel Hill, a premier institution known for its research in life sciences. Zhang's expertise includes T cell engineering, immune modulation, and intellectual property management.
Employment History
Prior to joining BeiGene, Lu Zhang held various positions at TCRCure Biopharma Corp. in the United States. His roles included Principal Scientist (2020-2021), Team Lead in T cell engineering and Immune Modulation; IP Management (2019-2021), and Senior Scientist (2018-2020). Additionally, Zhang worked as a Postdoctoral Research Associate at Duke University from 2014 to 2018.
International Experience
Lu Zhang has amassed considerable international work experience. He has worked in both the United States and China, which has provided him with a global perspective on biopharma research and development. His roles have spanned diverse functions such as research, team leadership, and intellectual property management.